skip to main content

IA Steroid in OA — SCE Rheumatology MCQ

Instant feedback + full explanation. One question, done properly.

EasyOsteoarthritisIA Steroid in OASCE Rheumatology

A 55-year-old woman with symptomatic bilateral knee osteoarthritis asks about intra-articular corticosteroid injections. According to current NICE guidance, which statement best describes their place in management?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: EConsider them when other pharmacological treatments are ineffective or unsuitable, or to support therapeutic exercise, explaining that relief lasts about 2 to 10 weeks.

Explanation lettering: D = shown as A · A = shown as B · B = shown as C · C = shown as D

The correct answer is E. NICE recommends considering an intra-articular corticosteroid injection when other pharmacological treatments are ineffective or unsuitable, or when short-term symptom control would support participation in therapeutic exercise. Patients should be told that benefit is temporary, typically lasting 2–10 weeks. Therapeutic exercise, together with weight management when appropriate, remains a core treatment, so injections are not first-line substitutes for exercise (B). They may be used before consideration of joint replacement and are not reserved for failed surgery (A). NICE recognises possible short-term benefit, making C incorrect. Fixed monthly maintenance injections are not recommended, and corticosteroids have not been shown to prevent structural progression (D).

Reference: National Institute for Health and Care Excellence. Osteoarthritis in over 16s: diagnosis and management (NG226), recommendation 1.4.10. 2022. https://www.nice.org.uk/guidance/ng226/chapter/recommendations